Epilepsy Drugs Market Size | Global Industry Analysis and Opportunity Assessment 2020-2025
Pune, Maharashtra, India, January 18 2021 (Wiredrelease) Brandessence Market Research and Consulting Pvt ltd –:Epilepsy Drugs Market is likely to reach nearly USD 5.5 Billion by the year end of 2021.
Market growth can be attributed to factors such as rising incidence of neurological disorders, growing disease awareness, introduction of novel antiepileptic drugs (AEDs), strong government support and initiatives. Moreover, increasing R&D investment and launch of extended-release formulations are further expected to fuel the market growth. However, high cost of patented drugs, concerns over decreasing healthcare costs as part of government austerity measures, particularly in Europe and low accessibility to antiepileptic drugs in low and middle income countries, are likely to restrict the market growth.
Get Sample of This Report@ https://brandessenceresearch.biz//Request/Sample?ResearchPostId=47618&RequestType=Sample
Vimpat is the undisputed leading drug of Global Epilepsy Drugs Market. It has a market share of nearly 22% in 2016 and is expected that Vimpat will gain its momentum till the forecasting period. Keppra was the second highest market share taker with more than 19% share in 2016 but the prospect of this drug will change due to the patent expiration in 2018 and its share decline to XX% by 2021. It is expected that Lamictal will be second leading drug with nearly XX% share by 2021. Onfi hold the third highest share of the Epilepsy Drugs market, being followed by Depakine by the year end of 2021.
The research report titled “Epilepsy Drugs Market: Global Demand, Growth Potential & Opportunity Outlook 2021” examines the market, competitive landscape and trends of the Global Epilepsy Drug Market. This report analyzes market data and provides a better understanding of Epilepsy Drugs sales value and demand in the Global Market. Market outlook in value terms for the forecasted period for Epilepsy Drugs Market has been detailed in the report. Key trends in terms of collaborations, partnerships and licensing agreements are analysed with details. The report also explores detailed description of growth drivers and inhibitors of the Global Epilpesy Drugs Market.
The report concludes with the profiles of major players in the Epilepsy Drugs Market such as UCB, EISAI, Pfizer, Sanofi and Lundbeck. The major market players are evaluated on various parameters such as company overview and latest development and trends in the Epilepsy Drugs Market
Key Topics Covered in the Report
Worldwide Epilepsy Drugs Market Analysis (2013 – 2021) Worldwide Epilepsy Drugs Market Share (2013 – 2021) Worldwide Epilepsy Drugs Brand Market Performance (2013 – 2021) Epilepsy Drugs Market – Major Deal Types Key Companies Analysis Key Drivers and Inhibitors of the Epilepsy Drugs Market
Key Epilepsy Drugs Covered in the Report are as follows:
Vimpat(Lacosamide) Keppra(Levetiracetam) Briviact(Brivaracetam) Lamictal(Lamotrigine) Neurontin (Gabapentin) Depakine (Sodium Valproate) Sabril (Vigabatrin) Onfi(Clobazam) Fycompa(Perampanel) Inovelon/Banzel(Rufinamide) Zonegran (Zonisamide) Zebinix (Eslicarbazepine Acetate)
Key Companies Covered in the Report are as follows:
UCB EISAI Pfizer Sanofi Lundbeck
Table of Content
1. Chapter – Report Methodology
1.1. Research Process
1.2. Primary Research
1.3. Secondary Research
1.4. Market Size Estimates
1.5. Data Triangulation
1.6. Forecast Model
1.7. USP’s of Report
1.8. Report Description
2. Chapter – Global Epilepsy Drugs Market Overview: Qualitative Analysis
2.1. Market Introduction
2.2. Executive Summary
2.3. Global Epilepsy Drugs Market Classification
2.4. Market Drivers
2.5. Market Restraints
2.6. Market Opportunity
2.7. Epilepsy Drugs Market: Trends
2.8. Porter’s Five Forces Analysis
2.9. Market Attractiveness Analysis
3. Chapter – Global Epilepsy Drugs Market Overview: Quantitative Analysis
4. Chapter – Global Epilepsy Drugs Market Analysis: Segmentation By Type
5. Chapter – Global Epilepsy Drugs Market Analysis: Segmentation By Application
Complete Report Details @ https://brandessenceresearch.biz/Lifesciences-and-Healthcare/Epilepsy-Drugs-Market/Summary
About Us: Brandessence Market Research and Consulting Pvt. ltd.
Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.
Contact us at: +44-2038074155 or mail us at firstname.lastname@example.org
Other Related Report:
This content has been published by Brandessence Market Research and Consulting Pvt ltd company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at email@example.com.